350 related articles for article (PubMed ID: 16583185)
21. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
22. Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.
Hofmann MA; Kiecker F; Küchler I; Kors C; Trefzer U
J Cancer Res Clin Oncol; 2011 Mar; 137(3):455-62. PubMed ID: 20454974
[TBL] [Abstract][Full Text] [Related]
23. In vivo production of type 1 cytokines in healthy sickle cell disease patients.
Taylor SC; Shacks SJ; Qu Z
J Natl Med Assoc; 1999 Nov; 91(11):619-24. PubMed ID: 10641497
[TBL] [Abstract][Full Text] [Related]
24. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
Baykal Y; Saglam K; Yilmaz MI; Taslipinar A; Akinci SB; Inal A
Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
[TBL] [Abstract][Full Text] [Related]
25. [Correlation analysis between cytokines levels in serum and bronchoalveolar lavage fluid, blood T cell subsets and pneumoconiosis severity].
Bian LQ; Zhou CC; Shi J; Chen ZD; Zhou SW; Bi Y; Mao L
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Apr; 30(4):255-7. PubMed ID: 22804931
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of IL-33 is increased in patients with ankylosing spondylitis.
Han GW; Zeng LW; Liang CX; Cheng BL; Yu BS; Li HM; Zeng FF; Liu SY
Clin Rheumatol; 2011 Dec; 30(12):1583-8. PubMed ID: 21968692
[TBL] [Abstract][Full Text] [Related]
28. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.
Kagaya A; Kugaya A; Takebayashi M; Fukue-Saeki M; Saeki T; Yamawaki S; Uchitomi Y
Neuropsychobiology; 2001; 43(2):59-62. PubMed ID: 11174046
[TBL] [Abstract][Full Text] [Related]
29. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.
Mehtap O; Atesoglu EB; Tarkun P; Hacihanefioglu A; Dolasik I; Musul MM
J Postgrad Med; 2014; 60(2):141-4. PubMed ID: 24823512
[TBL] [Abstract][Full Text] [Related]
30. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha, and IFN-v in acute coronary syndrome.
Wang YN; Che SM; Ma AQ
Chin Med Sci J; 2004 Jun; 19(2):120-4. PubMed ID: 15250248
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis.
Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J
J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053
[TBL] [Abstract][Full Text] [Related]
33. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis.
Barak V; Selmi C; Schlesinger M; Blank M; Agmon-Levin N; Kalickman I; Gershwin ME; Shoenfeld Y
J Autoimmun; 2009; 33(3-4):178-82. PubMed ID: 19846277
[TBL] [Abstract][Full Text] [Related]
34. Neopterin serum levels in pancreatic adenocarcinoma.
Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
[TBL] [Abstract][Full Text] [Related]
35. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.
Dlouhy I; Filella X; Rovira J; Magnano L; Rivas-Delgado A; Baumann T; Martínez-Trillos A; Balagué O; Martínez A; González-Farre B; Karube K; Gine E; Delgado J; Campo E; López-Guillermo A
Leuk Res; 2017 Aug; 59():20-25. PubMed ID: 28544905
[TBL] [Abstract][Full Text] [Related]
36. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the T helper 17 axis in ankylosing spondylitis.
Taylan A; Sari I; Kozaci DL; Yuksel A; Bilge S; Yildiz Y; Sop G; Coker I; Gunay N; Akkoc N
Rheumatol Int; 2012 Aug; 32(8):2511-5. PubMed ID: 21833527
[TBL] [Abstract][Full Text] [Related]
38. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
[TBL] [Abstract][Full Text] [Related]
40. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
